Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celator Pharmaceuticals Inc (NASDAQ:CPXX)

30.20
Delayed Data
As of Jun 28
 +0.03 / +0.10%
Today’s Change
1.12
Today|||52-Week Range
30.37
+1,615.91%
Year-to-Date
Why Celator Pharmaceuticals Is Up 1,610% in 2016
Jun 27 / MotleyFool.com - Paid Partner Content
4 Cancer Drug Developers You Need to Have on Your Radar This Year
Jun 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close30.17
Today’s open30.17
Day’s range30.15 - 30.22
Volume813,836
Average volume (3 months)3,683,348
Market cap$1.3B
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+8.06%
Earnings growth (this year)-4.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book161.58

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+2.38+7.04%
ALDRAlder Biopharmaceuti...+1.18+5.15%
ACORAcorda Therapeutics ...+0.83+3.39%
INVAInnoviva Inc+0.26+2.62%
Data as of 06/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$19.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Scott T. Jackson
President &
Chief Scientific Officer
Lawrence David Mayer
Corporate headquarters
Ewing, New Jersey

Forecasts

Partner Offers

Search for Jobs